Amass was founded by Alexander Junge, Henrik Jensen in 2022.

Who are Amass's investors?

Amass's investors include Novo Holdings, Giant Ventures Global Llp, Kost Capital.

Amass

Founded 2022 · 9 employees on LinkedIn · 3 known investors

Find your way into Amass

244 people in our graph share verified history with the Amass team — schools, employers, funds. One of them is your warm intro.

Tom McGinnunlockedknows Alexander Junge · together at Universität des Saarlandes (overlapped)

×2knows the team · via Novo Nordisk

×4knows the team · via Linköping University

×2knows the team · via Syddansk Universitet - University of Southern Denmark

×2knows the team · via University of Copenhagen

knows the team · via Universität des Saarlandes

Amass operates an agentic data platform that unifies over 500 million scientific documents — including research literature, patents, clinical trials, regulatory filings, and web sources — into a single engine that returns answers cited to their source. It serves researchers, life science companies, and research institutions through an app, API, and MCP interface, with each claim traceable to underlying evidence.

AI & Machine Learning Biotech Data & Infrastructure

Founders & leadership

Amass was founded in 2022 by Alexander Junge and Henrik Jensen.

Alexander Junge inCo-Founder & CTOAlexander Junge is co-founder and CTO of Amass, an agentic data platform unifying scientific documents for life sciences and pharma. Previously, he led machine learning and AI teams at Corti, a healthcare startup, and developed AI-powered medical coding solutions.

Henrik JenseninCo-Founder & CEO

Investors · 3

Novo Holdings✓ verifiedCopenhagen · $1.1M – $54M

Giant Ventures Global LlpLondon · $10M – $20M

Kost CapitalFrederiksberg

Competitors · 1

by search overlap

Omass4 shared keywordsOMass is a biotech company that originated as a spinout from Oxford University, developing specialized treatments for patient populations with high unmet medical needs. The company builds integrated development and commercialization capabilities while partnering to advance programs addressing large indications.

Companies competing with Amass for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Amass Brands raises SAFE to $1,735,000 | AMSS 8-K Filingstocktitan.net · Jun 2026

Amass' CEO has raised millions for his alcohol startups, but now he's crowdfunding part of his next round after seeing the value of fans-turned-investorsbusinessinsider.com · May 2021

Frequently asked questions

What does Amass do?: Amass operates an agentic data platform that unifies over 500 million scientific documents — including research literature, patents, clinical trials, regulatory filings, and web sources — into a single engine that returns answers cited to their source. It serves researchers, life science companies, and research institutions through an app, API, and MCP interface, with each claim traceable to underlying evidence.
Who founded Amass?: Amass was founded by Alexander Junge, Henrik Jensen in 2022.
Who are Amass's investors?: Amass's investors include Novo Holdings, Giant Ventures Global Llp, Kost Capital.